HENRY HARRELL: Open Payments
NPI 1104817907 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 25 payments from 10 companies in 2025. Trend: 2023 $108 · 2024 $512 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $191 |
| Lilly USA, LLC | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Astellas Pharma US Inc | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, MOUNJARO, TRELEGY ELLIPTA, Wegovy, Veozah, VOQUEZNA, TZIELD, INSPIRE.
Industry payments across TN — which companies pay providers there.
